A Registration Study on Depression in Patients With Epilepsy
- Conditions
- DepressionEpilepsy
- Registration Number
- NCT03247764
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.
- Detailed Description
As the treatment rate for depression in epilepsy is unclear and the discordant voice of choosing antidepressants for most doctors, this prospective observational cohort study was designed to better understand the current situation of drug treatments in patients with the comorbidity of epilepsy and depression in East China. The secondary outcome was to investigate whether baseline depressive symptoms had an influence on seizure-control in patients with epilepsy at follow-up.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 320
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the drug treatment rate of depression in patients with epilepsy 6 months the drug treatment rate at baseline and 6 months at follow-up
- Secondary Outcome Measures
Name Time Method the influence of depression on seizure-control 6 months whether depression at baseline affects seizure-control 6 months later
Trial Locations
- Locations (7)
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China
🇨🇳Shanghai, Shanghai, China
Nanjing Brain Hospital
🇨🇳Nanjing, China
The First Affiliated Hospital of Wenzhou Medical University
🇨🇳Wenzhou, China
Anhui Provincial Hospital
🇨🇳Hefei, China
Shanghai General Hospital
🇨🇳Shanghai, China
The Second Affiliated Hospital of Suzhou University
🇨🇳Suzhou, China
Department of Neurology, Second Affiliated Hospital of Zhejiang University School of Medicine
🇨🇳Hangzhou, Zhejiang, China